Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ensem Therapeutics
Atavistik Bio, Inc
Eisai Inc.
PMV Pharmaceuticals, Inc
Mayo Clinic
NiKang Therapeutics, Inc.
Kivu Bioscience Inc.
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Alterome Therapeutics, Inc.
Rutgers, The State University of New Jersey
Eli Lilly and Company
BeOne Medicines
National Institutes of Health Clinical Center (CC)
University College Cork
Bayer
Genmab
Genmab
Psyence Australia Pty Ltd
Convalife (Shanghai) Co., Ltd.
Eli Lilly and Company
Eli Lilly and Company
Terremoto Biosciences Inc.
Genmab
Jazz Pharmaceuticals
Kaiser Permanente
Seagen Inc.
Duke University
AstraZeneca
Radiopharm Theranostics, Ltd
Myeloid Therapeutics
Tizona Therapeutics, Inc
AstraZeneca
Normunity AccelCo, Inc.
NiKang Therapeutics, Inc.
IDEAYA Biosciences
MacroGenics
City of Hope Medical Center
Cogent Biosciences, Inc.
SystImmune Inc.
DualityBio Inc.
Daiichi Sankyo
Radiopharm Theranostics, Ltd
Second Life Therapeutics
Eli Lilly and Company
Shanghai Best-Link Bioscience, LLC
Medical College of Wisconsin
Seagen Inc.
Fusion Pharmaceuticals Inc.